We are live on ! Find out more
TIP

Torray Investment Partners Portfolio holdings

AUM $741M
1-Year Est. Return 26.16%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.59%
AUM
$555M
AUM Growth
+$53.4M
Cap. Flow
+$2.47M
Cap. Flow %
0.44%
Top 10 Hldgs %
27.17%
Holding
110
New
10
Increased
31
Reduced
50
Closed
6

Top Sells

Rank Stock Value
1
GPC icon
Genuine Parts
GPC
+$13.1M
2
TROW icon
T. Rowe Price
TROW
+$6.69M
3
GM icon
General Motors
GM
+$5.19M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.24M
5
SLB icon
SLB Ltd
SLB
+$3.37M

Sector Composition

Rank Sector Weight
1 Financials 20.6%
2 Technology 19.5%
3 Healthcare 14.65%
4 Industrials 11.35%
5 Consumer Discretionary 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JKHY icon
76
Jack Henry & Associates
JKHY
$11.1B
$1.37M 0.25%
7,783
-305
-4% -$56.3K
ANSS
77
DELISTED
Ansys
ANSS
$1.32M 0.24%
5,445
+996
+22% +$232K
BND icon
78
Vanguard Total Bond Market
BND
$161B
$1.27M 0.23%
17,640
AZPN
79
DELISTED
Aspen Technology Inc
AZPN
$1.24M 0.22%
6,061
-169
-3% -$39.3K
ICFI icon
80
ICF International
ICFI
$1.72B
$1.22M 0.22%
12,317
-484
-4% -$52.7K
VRRM icon
81
Verra Mobility
VRRM
$744M
$1.2M 0.22%
86,940
-3,099
-3% -$47.1K
MPWR icon
82
Monolithic Power Systems
MPWR
$68.9B
$1.13M 0.2%
3,209
-86
-3% -$30.9K
DT icon
83
Dynatrace
DT
$14.2B
$1.13M 0.2%
29,620
+2,857
+11% +$104K
BMRN icon
84
BioMarin Pharmaceuticals
BMRN
$12.4B
$1.12M 0.2%
10,834
-466
-4% -$43.7K
RCKT icon
85
Rocket Pharmaceuticals
RCKT
$394M
$1.06M 0.19%
54,324
-2,627
-5% -$48.4K
BPMC
86
DELISTED
Blueprint Medicines
BPMC
$1.03M 0.18%
23,436
+5,949
+34% +$285K
ZBRA icon
87
Zebra Technologies
ZBRA
$17.8B
$1.01M 0.18%
3,958
-406
-9% -$105K
QLYS icon
88
Qualys
QLYS
$6.35B
$931K 0.17%
8,297
-331
-4% -$41.4K
LNTH icon
89
Lantheus
LNTH
$6.59B
$885K 0.16%
+17,358
New +$1.07M
ENTG icon
90
Entegris
ENTG
$23.2B
$857K 0.15%
+13,072
New +$963K
CHD icon
91
Church & Dwight Co
CHD
$24.5B
$812K 0.15%
10,073
-426
-4% -$32.7K
NTRA icon
92
Natera
NTRA
$46.4B
$789K 0.14%
19,643
+2,903
+17% +$120K
IWF icon
93
iShares Russell 1000 Growth ETF
IWF
$128B
$579K 0.1%
10,804
+2,760
+34% +$152K
GOOG icon
94
Alphabet (Google) Class C
GOOG
$4.32T
$557K 0.1%
6,280
SPNS
95
DELISTED
Sapiens International
SPNS
$483K 0.09%
26,152
-17,051
-39% -$321K
SBUX icon
96
Starbucks
SBUX
$120B
$467K 0.08%
4,710
VICR icon
97
Vicor
VICR
$10.2B
$433K 0.08%
8,054
-1,489
-16% -$78.3K
VOT icon
98
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.8B
$407K 0.07%
+2,262
New +$410K
MUB icon
99
iShares National Muni Bond ETF
MUB
$45.9B
$396K 0.07%
3,750
COST icon
100
Costco
COST
$420B
$306K 0.06%
670

Similar funds

Torray Investment Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Torray Investment Partners held 110 positions worth $555M, up 11% from $502M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Torray Investment Partners's Q4 2022 filing shows 10 new, 31 increased, 50 reduced and 6 closed positions. Its largest new stake was Advance Auto Parts: 57,424 shares worth $8.44M. The largest sale was Genuine Parts, an estimated $13.1M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.

  • Torray Investment Partners's largest Q4 2022 buy was Advance Auto Parts: 57,424 shares worth $8.44M.
  • Torray Investment Partners added most to Fiserv Inc in Q4 2022, an estimated $9.88M increase.
  • Torray Investment Partners's biggest Q4 2022 reduction was T. Rowe Price, cutting an estimated $6.69M.
  • Torray Investment Partners fully exited Genuine Parts in Q4 2022, selling an estimated $13.1M.
  • Torray Investment Partners's ten largest holdings make up 27% of its $555M portfolio in Q4 2022.
  • Torray Investment Partners opened 10 new positions and closed 6 in Q4 2022.
  • Torray Investment Partners's portfolio value rose 11% quarter-over-quarter to $555M.

Based on Torray Investment Partners's 13F filing for Q4 2022, filed 8 Feb 2023.